Valacyclovir Hydrochloride
500 mg / 1 g tablets
Film-coated tablet
No Cambodian product registration or marketing authorisation is held for this presentation. The company states that registration of this presentation in Cambodia is in process.
Identity
The fields below reproduce the company’s product identity record.
| Field | Record |
|---|---|
| Active ingredient or supplied substance name | Valacyclovir Hydrochloride |
| Strength | 500 mg / 1 g tablets |
| Form or presentation | Film-coated tablet |
| Pack presentation | Blister or bottle of 10, 20 or 30 tablets |
Where a record lists more than one strength or presentation, each combination requires its own evidence.
Status and interpretation
GALVANTA COMPANY LIMITED holds no pharmaceutical manufacturing licence or GMP certificate.
This record does not establish permission to manufacture, advertise or supply the presentation. It is not approved prescribing information. Strength and total container contents must not be interpreted as a dose.
A packaging image does not establish registration, released stock or authenticity.
Documentary enquiries
Documentation may be requested through [email protected] or the Contact page. Identify the exact record, jurisdiction, requesting organisation and document required.
A request does not establish that the document exists or can be released. Do not send patient records or confidential technical information in an initial enquiry.
Reporting concerns
Use Adverse-event reporting for an unwanted medical occurrence and Product-quality concerns for a suspected defect or recall correspondence.